Tigermed repurchases 3.07 million A-shares for RMB121.70 million, treasury stock rises to 10.51 million

Bulletin Express06-11 19:41

Hangzhou Tigermed Consulting Co., Ltd. (Tigermed) disclosed that on 11 June 2026 it bought back 3.07 million A-shares on the Shenzhen Stock Exchange, spending RMB121.70 million in total. The shares were repurchased at prices ranging from RMB39.13 to RMB39.96 per share, with a volume-weighted average price of RMB39.61.

Prior to the transaction (as of 10 June 2026), Tigermed had 730.47 million issued shares (excluding treasury shares) and 7.43 million treasury shares, for a total of 737.90 million shares in issue. The latest buyback reduced the number of issued shares (excluding treasury shares) by 0.42% to 727.39 million and lifted the treasury-share balance to 10.51 million. The overall number of shares in issue remains unchanged at 737.90 million.

The company confirmed that the repurchase complied with both Hong Kong Stock Exchange Main Board Rules and the relevant Shenzhen Stock Exchange regulations.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1139502487?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-06-11 19:41","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1139502487","market":"hk","top_or_hot":-1,"title":"Tigermed repurchases 3.07 million A-shares for RMB121.70 million, treasury stock rises to 10.51 million","media":"Bulletin Express","content":"<p>Hangzhou Tigermed Consulting Co., Ltd. (Tigermed) disclosed that on 11 June 2026 it bought back 3.07 million A-shares on the Shenzhen Stock Exchange, spending RMB121.70 million in total. The shares were repurchased at prices ranging from RMB39.13 to RMB39.96 per share, with a volume-weighted average price of RMB39.61.</p>\n<p>Prior to the transaction (as of 10 June 2026), Tigermed had 730.47 million issued shares (excluding treasury shares) and 7.43 million treasury shares, for a total of 737.90 million shares in issue. The latest buyback reduced the number of issued shares (excluding treasury shares) by 0.42% to 727.39 million and lifted the treasury-share balance to 10.51 million. The overall number of shares in issue remains unchanged at 737.90 million.</p>\n<p>The company confirmed that the repurchase complied with both Hong Kong Stock Exchange Main Board Rules and the relevant Shenzhen Stock Exchange regulations.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Tigermed repurchases 3.07 million A-shares for RMB121.70 million, treasury stock rises to 10.51 million</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTigermed repurchases 3.07 million A-shares for RMB121.70 million, treasury stock rises to 10.51 million\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-06-11 19:41</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Hangzhou Tigermed Consulting Co., Ltd. (Tigermed) disclosed that on 11 June 2026 it bought back 3.07 million A-shares on the Shenzhen Stock Exchange, spending RMB121.70 million in total. The shares were repurchased at prices ranging from RMB39.13 to RMB39.96 per share, with a volume-weighted average price of RMB39.61.</p>\n<p>Prior to the transaction (as of 10 June 2026), Tigermed had 730.47 million issued shares (excluding treasury shares) and 7.43 million treasury shares, for a total of 737.90 million shares in issue. The latest buyback reduced the number of issued shares (excluding treasury shares) by 0.42% to 727.39 million and lifted the treasury-share balance to 10.51 million. The overall number of shares in issue remains unchanged at 737.90 million.</p>\n<p>The company confirmed that the repurchase complied with both Hong Kong Stock Exchange Main Board Rules and the relevant Shenzhen Stock Exchange regulations.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"03347","symbol_name":"泰格医药","start_time":0,"source_url":"","article_id":"1139502487","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1139502487","pubTimestamp":1781178094,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Hangzhou Tigermed Consulting Co., Ltd. (Tigermed) disclosed that on 11 June 2026 it bought back 3.07 million A-shares on the Shenzhen Stock Exchange, spending RMB121.70 million in total. The shares...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"03347":"泰格医药"},"translate_title":"泰格医药以1.217亿元回购307万股A股库存股升至1051万股","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"03347":1},"content_text":"Hangzhou Tigermed Consulting Co., Ltd. (Tigermed) disclosed that on 11 June 2026 it bought back 3.07 million A-shares on the Shenzhen Stock Exchange, spending RMB121.70 million in total. The shares were repurchased at prices ranging from RMB39.13 to RMB39.96 per share, with a volume-weighted average price of RMB39.61.\nPrior to the transaction (as of 10 June 2026), Tigermed had 730.47 million issued shares (excluding treasury shares) and 7.43 million treasury shares, for a total of 737.90 million shares in issue. The latest buyback reduced the number of issued shares (excluding treasury shares) by 0.42% to 727.39 million and lifted the treasury-share balance to 10.51 million. The overall number of shares in issue remains unchanged at 737.90 million.\nThe company confirmed that the repurchase complied with both Hong Kong Stock Exchange Main Board Rules and the relevant Shenzhen Stock Exchange regulations.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"shareholding,buyback,SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.43.1","shortVersion":"4.43.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1139502487","isCrawlerRequest":true}